Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFMW) Change in Taxes (2022 - 2025)

Historic Change in Taxes for Sunshine Biopharma (SBFMW) over the last 4 years, with Q3 2025 value amounting to $162992.0.

  • Sunshine Biopharma's Change in Taxes fell 6865.8% to $162992.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $68422.0, marking a year-over-year decrease of 7584.77%. This contributed to the annual value of -$812080.0 for FY2024, which is 100868.7% down from last year.
  • According to the latest figures from Q3 2025, Sunshine Biopharma's Change in Taxes is $162992.0, which was down 6865.8% from $30043.0 recorded in Q2 2025.
  • Over the past 5 years, Sunshine Biopharma's Change in Taxes peaked at $1.0 million during Q4 2023, and registered a low of -$1.2 million during Q2 2024.
  • Moreover, its 4-year median value for Change in Taxes was -$5059.0 (2025), whereas its average is -$41147.8.
  • Its Change in Taxes has fluctuated over the past 5 years, first skyrocketed by 32354.88% in 2023, then plummeted by 53083.8% in 2024.
  • Over the past 4 years, Sunshine Biopharma's Change in Taxes (Quarter) stood at $238679.0 in 2022, then skyrocketed by 323.55% to $1.0 million in 2023, then tumbled by 108.35% to -$84452.0 in 2024, then skyrocketed by 293.0% to $162992.0 in 2025.
  • Its Change in Taxes stands at $162992.0 for Q3 2025, versus $30043.0 for Q2 2025 and -$40161.0 for Q1 2025.